What are the different tests for diagnosing syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Tests for Syphilis

The diagnosis of syphilis requires both nontreponemal and treponemal tests, as neither type alone is sufficient for a definitive diagnosis. 1

Types of Syphilis Tests

Direct Detection Methods

  • Darkfield microscopy: Examination of lesion exudate or tissue to directly visualize Treponema pallidum spirochetes 1
  • Direct fluorescent antibody (DFA) tests: Uses fluorescent-labeled antibodies to detect T. pallidum in lesion specimens 1
  • Biopsy with silver stain: Histological examination of tissue samples 1

Nontreponemal Tests

These detect antibodies to cardiolipin (antiphospholipid antibodies) produced during infection:

  1. Rapid Plasma Reagin (RPR):

    • Widely used screening test
    • Quantitative results reported as titers (e.g., 1:4,1:8)
    • Sensitivity: 71-100% (varies by stage)
    • Higher sensitivity than VDRL in some studies 2
    • Automated versions now available 1
  2. Venereal Disease Research Laboratory (VDRL):

    • Traditional screening test
    • Can be performed on serum or cerebrospinal fluid (CSF)
    • Sensitivity: 71-100% (varies by stage)
    • Only nontreponemal test validated for CSF testing 1
  3. Toluidine Red Unheated Serum Test (TRUST):

    • Less commonly used alternative to RPR/VDRL 1
    • Similar performance characteristics

Treponemal Tests

These detect specific antibodies against T. pallidum:

  1. Fluorescent Treponemal Antibody Absorption (FTA-ABS):

    • Traditional confirmatory test
    • Sensitivity: 96.3% overall 3
    • Can be performed on CSF but less specific than VDRL-CSF 1
  2. Treponema pallidum Particle Agglutination (TP-PA):

    • Highly sensitive confirmatory test
    • Sensitivity: 86% in primary syphilis (higher than nontreponemal tests) 2
    • Often used as reference standard 4
  3. Enzyme Immunoassay (EIA)/Chemiluminescence Immunoassay (CIA):

    • Automatable treponemal tests
    • Increasingly used as initial screening tests in reverse sequence algorithms
    • Sensitivity: up to 100% in some studies 3
    • Examples include CAPTIA IgG, Trep-Sure, LIAISON, etc. 4
  4. Point-of-Care Treponemal Tests:

    • Rapid diagnostic tests for field settings
    • Examples include BIOLINE, Trep-ID 4

Testing Algorithms

Traditional Algorithm

  1. Screen with nontreponemal test (RPR or VDRL)
  2. If reactive, confirm with treponemal test (FTA-ABS, TP-PA)
  3. Sensitivity: 71% for primary syphilis 2

Reverse Sequence Algorithm

  1. Screen with treponemal test (EIA/CIA)
  2. If reactive, perform nontreponemal test (RPR or VDRL)
  3. If discordant (treponemal reactive, nontreponemal nonreactive), perform second treponemal test (TP-PA or FTA-ABS)
  4. Sensitivity: potentially higher for early primary syphilis 5

Performance by Stage of Syphilis

Primary Syphilis

  • Darkfield microscopy: Most definitive for early diagnosis 1
  • Nontreponemal tests: 71-86% sensitivity 2
  • Treponemal tests: 86-100% sensitivity 3, 2
  • TP-PA has higher sensitivity than VDRL/RPR in this stage 2

Secondary Syphilis

  • Nontreponemal tests: Nearly 100% sensitivity 1, 3
  • Treponemal tests: 98-100% sensitivity 3

Early Latent Syphilis

  • Nontreponemal tests: 82-100% sensitivity 1
  • Treponemal tests: High sensitivity (>95%) 3

Late Latent Syphilis

  • Nontreponemal tests: 61-75% sensitivity 1
  • Treponemal tests: Remain highly sensitive (>95%) 3

Neurosyphilis

  • CSF examination required:
    • CSF-VDRL: Highly specific but insensitive 1
    • CSF leukocyte count: Usually elevated (>5 WBCs/mm³) 1
    • CSF protein: Often elevated 1
    • CSF FTA-ABS: More sensitive but less specific than VDRL-CSF 1
  • No single test is diagnostic; combination of tests needed 1

Important Considerations

Test Interpretation

  • Quantitative monitoring: Nontreponemal test titers correlate with disease activity and should be used to monitor treatment response 1
  • Fourfold titer change: Equivalent to two dilutions (e.g., 1:16 to 1:4), indicates significant clinical difference 1
  • Serofast reaction: Persistent low-titer nontreponemal antibodies despite treatment 1
  • Treponemal tests: Usually remain reactive for life regardless of treatment 1

Special Populations

  • HIV-infected patients:
    • May have atypical serologic responses (unusually high, low, or fluctuating titers) 1
    • Lower sensitivity of traditional algorithm (55% vs 77% in HIV-negative) 2
    • Consider direct detection methods if serologic tests are inconclusive 1

Pitfalls and Caveats

  • RPR and VDRL titers are not directly comparable; sequential tests should use the same method 1
  • False-positive nontreponemal tests can occur in various medical conditions 1
  • Prozone phenomenon can cause false-negative results in high-titer specimens 1
  • In very early primary syphilis, all serologic tests may be negative 1
  • Biological false positives are more common in low-prevalence populations 5

Follow-up Testing

  • Quantitative nontreponemal tests should be performed at regular intervals after treatment 6
  • Successful treatment typically shows fourfold decrease in titer within 6 months for primary/secondary syphilis and 12-24 months for latent/late syphilis 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.